Struggling with Hair Loss from Androgenetic Alopecia?
A Clinical Trial may be the answer!
Androgenetic Alopecia (AGA) commonly known as male pattern baldness is a progressive hair loss condition that affects millions of men and women worldwide. Primarily driven by genetics and hormonal changes, AGA typically begins with a receding hairline, thinning at the crown, and continues to progress over time.
At Revival Research Institute, we are conducting a clinical trial to explore potential treatment options for androgenetic alopecia, aiming to slow hair loss and possibly stimulate regrowth. This research study represents a vital step toward advancing hair loss therapies and bringing new hope to individuals affected by AGA.
By choosing to participate, you’re not only exploring potential solutions for your own hair loss but also helping move the science of hair restoration forward. Your care is our top priority throughout the trial, with a dedicated focus on safety, respect, and ongoing support every step of the way.
Interested in Signing Up for an Androgenetic Alopecia Clinical Trial?
To sign up and participate, individuals must meet the following eligibility criteria:
- Males, aged 18 years or older
- Suffering hair loss in the temple region or the top of the head
- Have experienced chronic symptoms for at least one year prior to screening
*Additional criteria may apply.
Participation in the Androgenetic Alopecia Clinical Trials is free of cost. To learn more about the clinical trial or to sign up, fill out the form below. Someone from our research team will contact you to discuss your potential eligibility for the study.
About Androgenetic Alopecia Clinical Trials
Experiencing androgenetic alopecia can take a toll on one’s self-esteem and emotional well-being. This common form of hair loss causes progressive thinning and balding, often affecting both men and women and influencing daily confidence. Androgenetic alopecia affects up to 50% of men by the age of 50 and approximately 38% of women over the age of 70, making it the most prevalent form of hair loss globally.
Revival Research Institute is conducting a clinical trial to evaluate the safety and effectiveness of investigational medications that may help slow hair loss and promote regrowth in individuals with AGA. This study is designed to collect valuable data that may improve future research, treatment options, and outcomes for those affected by this condition.
Androgenetic Alopecia Clinical Trials are being conducted at select locations across the United States, including Michigan. To ensure eligibility, all participants must follow the study procedures. Those who meet the eligibility criteria and enroll in the study may receive either investigational treatment or a placebo.
*All study procedures and study-related treatments, including the investigational drug, are provided at no cost, and no insurance is required to participate. Participants may also receive compensation for time and travel.
*To take the next step, submit the form above, and our research staff will contact you to determine if you qualify for the study.
Get Started
What to Expect?
If you are living with androgenetic alopecia, you may qualify for a paid clinical trial exploring new treatment options. After completing the interest form above, a member of our research team will contact you for a brief pre-screening to determine if you meet the initial eligibility criteria.
If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which outlines all study procedures, potential benefits, and possible risks. Once consent is given, you will be invited to one of our research sites for a screening visit. During this visit, we will review your medical history, conduct physical exams, and perform lab tests to further assess your eligibility. If you meet all study requirements, you may be officially enrolled in the clinical trial.
Our team is committed to ensuring you fully understand your role in the study and what to expect throughout the trial. Please feel free to ask any questions before deciding to participate. Your involvement helps advance future treatment options for Androgenetic Alopecia.
Age
18+ years
Condition
Androgenetic Alopecia
Location
Michigan
Struggling with the Effects of Androgenetic Alopecia?
Discover New Possibilities Through Clinical Studies
Androgenetic alopecia (AGA), commonly referred to as male pattern baldness, is the most common form of hair loss in men. It typically begins with a receding hairline or thinning at the crown and progresses gradually, often leading to partial or complete baldness. AGA is caused by a combination of genetics and hormonal activity, particularly sensitivity to dihydrotestosterone (DHT), which causes the hair follicles to shrink over time.
Beyond the physical changes, AGA can have a deep psychological impact. Many individuals report increased self-consciousness, reduced confidence, and emotional stress related to their appearance. Social interactions, professional situations, and even daily routines can be affected by the emotional toll of ongoing hair loss.
Androgenetic Alopecia Can Be Caused By
- Genetic predisposition inherited from one or both parents.
- Hormonal changes, particularly sensitivity to dihydrotestosterone (DHT).
- Age-related hair follicle shrinkage leads to gradual hair thinning.
Symptoms of Androgenetic Alopecia
- Gradual thinning of hair, typically starting at the crown or hairline.
- Increased hair shedding with reduced hair density or complete baldness over time.
Frequently Asked Questions
Your Guide to Common Questions
Got questions about Androgenetic Alopecia?
We’ve compiled answers to some of the most common questions about the condition—what causes it, how it’s treated, and what daily life with this condition can look like. Still can’t find what you’re looking for? Our team is here to help. Call us on (248) 721-9539, and we’ll be happy to assist you.
